Loading company…
Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.
SIRPANT IMMUNOTHERAPEUTICS INC has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $2,399,999 between 2021 and 2023. These are non-dilutive federal research grants, not equity financing. The company is based in HUMMELSTOWN, Pennsylvania.
No investors recorded yet for SIRPANT IMMUNOTHERAPEUTICS INC.
Add an investorSIRPANT IMMUNOTHERAPEUTICS INC has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for SIRPANT IMMUNOTHERAPEUTICS INC.
Add diversity data